Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2024-06-17 Sale |
2024-06-20 4:17 pm |
Oncology Institute Inc. | TOI | Hively Brad Director |
18,121 | $0.4578 | $8,296 | 676,203 (Direct) |
View |
2024-05-22 Sale |
2024-05-23 7:22 pm |
Oncology Institute Inc. | TOI | Hively Brad Director |
19,526 | $0.5753 | $11,233 | 694,324 (Direct) |
View |
2024-05-21 Sale |
2024-05-23 6:33 pm |
Oncology Institute Inc. | TOI | Virnich Daniel Chief Executive Officer |
11,173 | $0.5972 | $6,673 | 1,413,240 (Direct) |
View |
2024-01-29 Sale |
2024-01-30 7:07 pm |
Oncology Institute Inc. | TOI | Havencrest Healthcare Partners L.P. Havencrest Healthcare Partners GP LLC TOI HC I LLC 10% Owner |
8,637 | $2.12 | $18,310 | 8,801,823 (Indirect) |
View |
2024-01-24 Sale |
2024-01-26 7:19 pm |
Oncology Institute Inc. | TOI | Havencrest Healthcare Partners L.P. Havencrest Healthcare Partners GP LLC TOI HC I LLC 10% Owner |
43,776 | $2.2121 | $96,835 | 8,810,460 (Indirect) |
View |
2024-01-19 Sale |
2024-01-23 8:02 pm |
Oncology Institute Inc. | TOI | Havencrest Healthcare Partners L.P. Havencrest Healthcare Partners GP LLC TOI HC I LLC 10% Owner |
27,587 | $2.1224 | $58,551 | 8,854,236 (Indirect) |
View |
2023-12-14 Purchase |
2023-12-18 3:26 pm |
Oncology Institute Inc. | TOI | Shah Mihir Chief Financial Officer |
100,000 | $1.2699 | $126,989 | 328,122 (Direct) |
View |
2023-11-21 Sale |
2023-11-22 9:01 pm |
Oncology Institute Inc. | TOI | Hively Brad Director |
25,867 | $2.193 | $56,726 | 671,198 (Direct) |
View |
2023-11-21 Sale |
2023-11-22 8:47 pm |
Oncology Institute Inc. | TOI | Virnich Daniel Chief Executive Officer |
4,322 | $2.193 | $9,478 | 729,603 (Direct) |
View |
2023-11-21 Sale |
2023-11-22 8:37 pm |
Oncology Institute Inc. | TOI | Podnos Yale Chief Medical Officer |
1,530 | $2.193 | $3,355 | 86,838 (Direct) |
View |
2023-11-17 Sale |
2023-11-21 7:27 pm |
Oncology Institute Inc. | TOI | Hively Brad Director |
25,000 | $2.24 | $56,000 | 2,442,496 (Direct) |
View |
2023-11-14 Sale |
2023-11-16 4:40 pm |
Oncology Institute Inc. | TOI | Podnos Yale Chief Medical Officer |
2,098 | $2.3851 | $5,004 | 88,368 (Direct) |
View |
2023-11-14 Sale |
2023-11-16 3:56 pm |
Oncology Institute Inc. | TOI | Virnich Daniel Chief Executive Officer |
4,604 | $2.385 | $10,981 | 733,925 (Direct) |
View |
2023-11-13 Sale |
2023-11-15 6:49 pm |
Oncology Institute Inc. | TOI | Hively Brad Director |
74,117 | $2.4736 | $183,336 | 2,467,496 (Direct) |
View |
2023-05-23 Sale |
2023-05-24 8:43 pm |
Oncology Institute Inc. | TOI | Shah Mihir Chief Financial Officer |
3,442 | $0.428 | $1,473 | 223,472 (Direct) |
View |
2023-03-17 Purchase |
2023-03-21 9:01 pm |
Oncology Institute Inc. | TOI | BARASCH RICHARD A Director |
50,000 | $0.54991 | $27,495 | 257,201 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2024-11-12 Other |
2024-11-18 6:52 pm |
N/A N/A |
Oncology Institute Inc. | TOI | Pacala Mark L Director |
50,620 | $0 | 135,029 (Direct) |
View |
2024-11-12 Other |
2024-11-18 6:50 pm |
N/A N/A |
Oncology Institute Inc. | TOI | Virnich Daniel Chief Executive Officer |
195,236 | $0 | 916,947 (Direct) |
View |
Ownership |
2024-09-30 4:30 pm |
N/A N/A |
Oncology Institute Inc. | TOI | Carter Robert Ross Chief Financial Officer |
0 | $0 | 121,388 (Direct) |
View |
2024-08-16 Other |
2024-08-20 06:15 am |
N/A N/A |
Oncology Institute Inc. | TOI | Havencrest Healthcare Partners L.P. Havencrest Healthcare Partners GP LLC TOI HC I LLC 10% Owner |
16,333,241 | $0 | 16,585,867 (Indirect) |
View |
2024-05-21 Option Award |
2024-05-23 6:33 pm |
N/A 2034-05-21 |
Oncology Institute Inc. | TOI | Virnich Daniel Chief Executive Officer |
694,810 | $0 | 1,413,240 (Direct) |
View |
2024-05-21 Option Award |
2024-05-23 6:33 pm |
N/A 2034-05-21 |
Oncology Institute Inc. | TOI | Shah Mihir Chief Financial Officer |
530,107 | $0 | 853,579 (Direct) |
View |
2024-05-21 Option Award |
2024-05-23 6:33 pm |
N/A 2034-05-21 |
Oncology Institute Inc. | TOI | Podnos Yale Chief Medical Officer |
61,355 | $0 | 148,193 (Direct) |
View |
2024-05-21 Option Award |
2024-05-23 6:33 pm |
N/A 2034-05-21 |
Oncology Institute Inc. | TOI | Castle Jeremy Chief Operating Officer |
245,419 | $0 | 257,759 (Direct) |
View |
2023-12-28 Other |
2024-01-02 5:01 pm |
N/A N/A |
Oncology Institute Inc. | TOI | Havencrest Healthcare Partners L.P. Havencrest Healthcare Partners GP LLC TOI HC I LLC 10% Owner |
8,561,048 | $0 | 17,442,871 (Indirect) |
View |
2023-12-26 Option Award |
2023-12-28 5:58 pm |
N/A N/A |
Oncology Institute Inc. | TOI | BARASCH RICHARD A Director |
80,000 | $0 | 337,201 (Direct) |
View |
2023-12-26 Option Award |
2023-12-28 5:46 pm |
N/A N/A |
Oncology Institute Inc. | TOI | Hively Brad Director |
42,652 | $0 | 713,850 (Direct) |
View |
2023-12-26 Option Award |
2023-12-28 5:38 pm |
N/A N/A |
Oncology Institute Inc. | TOI | Johnson Karen Marie Director |
52,000 | $0 | 115,185 (Direct) |
View |
2023-12-26 Option Award |
2023-12-28 5:27 pm |
N/A N/A |
Oncology Institute Inc. | TOI | Kaushal Mohit Director |
53,326 | $0 | 121,253 (Direct) |
View |
2023-12-26 Option Award |
2023-12-28 5:16 pm |
N/A N/A |
Oncology Institute Inc. | TOI | Ling Gabriel Director |
40,000 | $0 | 69,057 (Direct) |
View |
2023-12-26 Option Award |
2023-12-28 5:06 pm |
N/A N/A |
Oncology Institute Inc. | TOI | McGeorge Anne Director |
56,000 | $0 | 127,346 (Direct) |
View |
2023-12-26 Option Award |
2023-12-28 4:58 pm |
N/A N/A |
Oncology Institute Inc. | TOI | O'Meara Maeve Director |
50,000 | $0 | 109,104 (Direct) |
View |
2023-12-26 Option Award |
2023-12-28 4:09 pm |
N/A N/A |
Oncology Institute Inc. | TOI | Pacala Mark L Director |
46,630 | $0 | 135,029 (Direct) |
View |
2023-11-30 Option Award |
2023-12-04 7:42 pm |
N/A 2033-11-30 |
Oncology Institute Inc. | TOI | Castle Jeremy Chief Operating Officer |
43,189 | $0 | 43,189 (Direct) |
View |
2023-11-17 Exercise |
2023-11-21 7:27 pm |
N/A N/A |
Oncology Institute Inc. | TOI | Hively Brad Director |
25,000 | $0.85 | 2,442,496 (Direct) |
View |
2023-11-17 Exercise |
2023-11-21 7:27 pm |
N/A 2029-12-02 |
Oncology Institute Inc. | TOI | Hively Brad Director |
25,000 | $0 | 2,442,496 (Direct) |
View |
2023-11-13 Exercise |
2023-11-15 6:49 pm |
N/A N/A |
Oncology Institute Inc. | TOI | Hively Brad Director |
47,000 | $0.85 | 2,467,496 (Direct) |
View |
2023-11-13 Exercise |
2023-11-15 6:49 pm |
N/A 2029-12-02 |
Oncology Institute Inc. | TOI | Hively Brad Director |
47,000 | $0 | 2,467,496 (Direct) |
View |
2023-03-17 Option Award |
2023-03-21 9:06 pm |
N/A N/A |
Oncology Institute Inc. | TOI | Kaushal Mohit Director |
19,685 | $0 | 42,393 (Direct) |
View |
2023-03-17 Option Award |
2023-03-21 9:04 pm |
N/A 2033-03-17 |
Oncology Institute Inc. | TOI | Podnos Yale Chief Medical Officer |
116,266 | $0 | 173,513 (Direct) |
View |
2023-03-17 Option Award |
2023-03-21 9:00 pm |
N/A 2033-03-17 |
Oncology Institute Inc. | TOI | Shah Mihir Chief Financial Officer |
616,668 | $0 | 667,391 (Direct) |
View |
2023-03-17 Option Award |
2023-03-21 8:56 pm |
N/A 2033-03-17 |
Oncology Institute Inc. | TOI | Miller Matthew P Chief Operating Officer |
236,836 | $0 | 412,161 (Direct) |
View |
2023-03-17 Option Award |
2023-03-21 8:52 pm |
N/A N/A |
Oncology Institute Inc. | TOI | SARIN RAVI YANG Director |
29,528 | $0 | 4,185,198 (Direct) |
View |